Blogopmaak

Erasmus+ student Janina Lösch joins the DCRT for an internship

Janina Lösch is a master student from University of Bonn doing an Erasmus+ internship at the DCRT. Her project focuses on allele selective ASOs targeting a heterozygous variant in ACTL6B that causes an intellectual development disorder. The idea is to inactivate the mutated allele while leaving the wild type allele intact, as heterozygous carriers of recessive mutations in ACTL6B are healthy.
Janina obtained her bachelor’s degree in Molecular Biomedicine after which she continued with a master’s program in Immunobiology, both at the University of Bonn. For her master thesis she investigated the effect of the menstrual cycle on blood immune cells.

Welcome to the DCRT, Janina!


posted on March 27, 2024

by duda-wsm 01 May, 2024
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
by duda-wsm 22 Apr, 2024
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
by duda-wsm 10 Apr, 2024
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
by duda-wsm 04 Apr, 2024
Student Nick van Dullemen joins the DCRT for an internship
Willeke van Roon-Mom will give a presentation at the CCMO symposium on 5 April 2024
by duda-wsm 04 Mar, 2024
DCRT's Willeke van Roon-Mom presents on antisense oligonucleotides at the CCMO symposium
by duda-wsm 29 Feb, 2024
It's Rare Disease Day and DCRT is celebrating her 4th birthday!
The 3rd DATS will be held on 23 and 24 May 2024 in Rotterdam. DCRT will organize a session on day 2.
by duda-wsm 12 Feb, 2024
DCRT session at the third Dutch Antisense Therapeutics Symposium
by duda-wsm 21 Dec, 2023
Merry Christmas from all of us at DCRT
DCRT's Marlen Lauffer is the lead of the N1C patient organization workgroup
by duda-wsm 21 Dec, 2023
Marlen Lauffer is highlighted member in this month's N1C newsletter.
by duda-wsm 18 Dec, 2023
Dream of Dutch Center for RNA Therapeutics in 'Best Idea' of the Netherlands and Flanders
More posts
Share by: